These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18811715)

  • 1. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus.
    Carruthers A; Carruthers J
    Dermatol Surg; 2008 Nov; 34(11):1486-99. PubMed ID: 18811715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
    Silvers SL; Eviatar JA; Echavez MI; Pappas AL
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
    Sadick NS; Katz BE; Roy D
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of injectable CaHA for the treatment of mid-face volume loss.
    Beer K; Yohn M; Cohen JL
    J Drugs Dermatol; 2008 Apr; 7(4):359-66. PubMed ID: 18459517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
    Tzikas TL
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.
    Moers-Carpi M; Vogt S; Santos BM; Planas J; Vallve SR; Howell DJ
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S144-51. PubMed ID: 18086052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.
    Moers-Carpi MM; Tufet JO
    Dermatol Surg; 2008 Feb; 34(2):210-5. PubMed ID: 18093199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds.
    Smith S; Busso M; McClaren M; Bass LS
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S112-21; discussion S121. PubMed ID: 18086048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy.
    Bechara FG; Gambichler T; Brockmeyer NH; Sand M; Altmeyer P; Hoffmann K
    Dermatology; 2008; 217(3):244-9. PubMed ID: 18663308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life.
    van Rozelaar L; Kadouch JA; Duyndam DA; Nieuwkerk PT; Lutgendorff F; Karim RB
    Aesthet Surg J; 2014 Jan; 34(1):118-32. PubMed ID: 24334306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions.
    Alam M; Yoo SS
    J Am Acad Dermatol; 2007 Feb; 56(2):285-9. PubMed ID: 17224371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
    Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of HIV-associated facial lipoatrophy with Radiance FN (Radiesse).
    Comite SL; Liu JF; Balasubramanian S; Christian MA
    Dermatol Online J; 2004 Oct; 10(2):2. PubMed ID: 15530292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective review of calcium hydroxylapatite for correction of volume loss in the infraorbital region.
    Hevia O
    Dermatol Surg; 2009 Oct; 35(10):1487-94. PubMed ID: 19614938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiance.
    Flaharty P
    Facial Plast Surg; 2004 May; 20(2):165-9. PubMed ID: 15643585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
    Lizzul PF; Narurkar VA
    J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds.
    Carruthers A; Liebeskind M; Carruthers J; Forster BB
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
    Jansen DA; Graivier MH
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable calcium hydroxylapatite microspheres (Radiesse).
    Ridenour B; Kontis TC
    Facial Plast Surg; 2009 May; 25(2):100-5. PubMed ID: 19415577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.